What does DR. M.R. TROMP do?

DR. M.R. TROMP is a specialist medical practice in Sint-Gillis-Waas. Private Limited, started on 30 June 2021, 1 establishment.

What is the address of DR. M.R. TROMP?

The registered office of DR. M.R. TROMP is located at Donkstraat(MD) 11, 9170 Sint-Gillis-Waas.

Is DR. M.R. TROMP still active?

Yes. According to the CBE (17 September 2026) DR. M.R. TROMP is active, legal situation “Normale toestand”, started on 30 June 2021.

Is DR. M.R. TROMP registered on Peppol?

Yes, DR. M.R. TROMP is registered on the Peppol network with ID 0208:0770537019.

What is the enterprise number of DR. M.R. TROMP?

The enterprise number of DR. M.R. TROMP is BE0770537019.

When was DR. M.R. TROMP founded?

DR. M.R. TROMP was founded on 30 June 2021.

Who are the directors of DR. M.R. TROMP?

According to the 2025 annual accounts, the directors of DR. M.R. TROMP are: Mike-Stephen Tromp.

Is DR. M.R. TROMP a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 30 June 2021; 4 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DR. M.R. TROMP make in 2025?

DR. M.R. TROMP posted a profit after taxes of € 29,702 in financial year 2025.

What is the revenue of DR. M.R. TROMP?

As a small company, DR. M.R. TROMP is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 32,084.

DR. M.R. TROMP (Private Limited) - Sint-Gillis-Waas

Dossier DR. M.R. TROMP, printed on 17 September 2026 from databakkes.be/en/0770537019/dr-m-r-tromp. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

DR. M.R. TROMP from Sint-Gillis-Waas, company number BE0770537019, closed financial year 2025 with a result of € 29,702 after tax. For that financial year DR. M.R. TROMP recorded a gross margin of € 32,084 and equity of € 57,991. Compared with financial year 2024, the result moved from € 924,161 to € 29,702. The company is profitable. The buffer shrank hard: equity is 94 % below last year. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on June 1, 2026.

What it is worth Shrank hard

€ 57,991

▼ 94% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 29,702

▼ 97% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 5,464

▼ 90% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 969,500 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt ≈ 1 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 21,531

▼ 43% vs 2024

€ 15,885 is repaid this year. At this pace the long-term loan is gone in ≈ 1 years.

Owed to suppliers

€ 1,560

▼ 41% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 13,532

▲ 15% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 105,490 Gross margin 2022: € 105,490 First fiscal year in the series	€ 34,209 Gross margin 2023: € 34,209 ▼ 68% vs 2022 (€ 105,490) Unfavourable step	€ 4,717 Gross margin 2024: € 4,717 ▼ 86% vs 2023 (€ 34,209) Unfavourable step	€ 32,084 Gross margin 2025: € 32,084 ▲ € 27,367 vs 2024 (€ 4,717) Favourable step	▲ € 27,367
Profit after taxes	€ 66,951 Profit after taxes 2022: € 66,951 First fiscal year in the series	€ 6,637 Profit after taxes 2023: € 6,637 ▼ 90% vs 2022 (€ 66,951) Unfavourable step	€ 924,161 Profit after taxes 2024: € 924,161 ▲ € 917,524 vs 2023 (€ 6,637) Favourable step	€ 29,702 Profit after taxes 2025: € 29,702 ▼ 97% vs 2024 (€ 924,161) Unfavourable step	▼ 97%
Equity	€ 68,651 Equity 2022: € 68,651 First fiscal year in the series	€ 73,628 Equity 2023: € 73,628 ▲ 7% vs 2022 (€ 68,651) Favourable step	€ 997,789 Equity 2024: € 997,789 ▲ € 924,161 vs 2023 (€ 73,628) Favourable step	€ 57,991 Equity 2025: € 57,991 ▼ 94% vs 2024 (€ 997,789) Unfavourable step	▼ 94%
Total debts	€ 114,337 Total debts 2022: € 114,337 First fiscal year in the series	€ 120,426 Total debts 2023: € 120,426 ▲ 5% vs 2022 (€ 114,337) Unfavourable step	€ 52,712 Total debts 2024: € 52,712 ▼ 56% vs 2023 (€ 120,426) Favourable step	€ 61,698 Total debts 2025: € 61,698 ▲ 17% vs 2024 (€ 52,712) Unfavourable step	▲ 17%
Cash	€ 53,505 Cash 2022: € 53,505 First fiscal year in the series	€ 74,822 Cash 2023: € 74,822 ▲ 40% vs 2022 (€ 53,505) Favourable step	€ 53,990 Cash 2024: € 53,990 ▼ 28% vs 2023 (€ 74,822) Unfavourable step	€ 5,464 Cash 2025: € 5,464 ▼ 90% vs 2024 (€ 53,990) Unfavourable step	▼ 90%
Retained profit	€ 66,151 Retained profit 2022: € 66,151 First fiscal year in the series	€ 71,128 Retained profit 2023: € 71,128 ▲ 8% vs 2022 (€ 66,151) Favourable step	€ 995,289 Retained profit 2024: € 995,289 ▲ € 924,161 vs 2023 (€ 71,128) Favourable step	€ 55,491 Retained profit 2025: € 55,491 ▼ 94% vs 2024 (€ 995,289) Unfavourable step	▼ 94%
Dividend	€ 800 Dividend 2022: € 800 First fiscal year in the series	€ 1,660 Dividend 2023: € 1,660 ▲ 108% vs 2022 (€ 800) Unchanged	€ 0 Dividend 2024: € 0 ▼ 100% vs 2023 (€ 1,660) Unchanged	€ 969,500 Dividend 2025: € 969,500 Unchanged (€ 0) Unchanged
Bank debt	€ 69,128 Bank debt 2022: € 69,128 First fiscal year in the series	€ 53,612 Bank debt 2023: € 53,612 ▼ 22% vs 2022 (€ 69,128) Favourable step	€ 37,749 Bank debt 2024: € 37,749 ▼ 30% vs 2023 (€ 53,612) Favourable step	€ 21,531 Bank debt 2025: € 21,531 ▼ 43% vs 2024 (€ 37,749) Favourable step	▼ 43%
Balance sheet total	€ 182,988 Balance sheet total 2022: € 182,988 First fiscal year in the series	€ 194,054 Balance sheet total 2023: € 194,054 ▲ 6% vs 2022 (€ 182,988) Unchanged	€ 1,050,501 Balance sheet total 2024: € 1,050,501 ▲ € 856,447 vs 2023 (€ 194,054) Unchanged	€ 119,689 Balance sheet total 2025: € 119,689 ▼ 89% vs 2024 (€ 1,050,501) Unchanged	▼ 89%

Key figures of DR. M.R. TROMP, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR. M.R. TROMP?

What happened at DR. M.R. TROMP in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 1, 2026 New annual accounts for financial year 2025: profit of € 29,702 (▼ 97% vs 2024). Source: NBB ↗
Jun 30, 2021 New establishment in Gent. KBO
2021 Mike-Stephen Tromp became a director. NBB
Jun 30, 2021 Start of the company according to the CBE. KBO

In short

From € 66,951 profit in 2022 to € 29,702 profit in 2025.

Paid € 34,375 in corporate taxes since 2022.

Best year ever: 2024, with € 924,161 profit.

Paid out € 971,960 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DR. M.R. TROMP? We notify you, reason included.

Follow DR. M.R. TROMP

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

Mike-Stephen Tromp

DR. M.R. TROMP

Faceland THB

Behind DR. M.R. TROMP is Mike-Stephen Tromp. Mike-Stephen Tromp is also behind Faceland THB.

See the full network in the app

Directors

According to the 2025 annual accounts

Mike-Stephen Tromp

Director

Also active at: Faceland THB

since 2021

Establishments

Establishment units

Physical locations of this company

Registered office

Donkstraat(MD) 11

9170 Sint-Gillis-Waas

2.319.771.628

Brabantdam 207

9000 Gent

Active since 30 June 2021

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0770.537.019
VAT number: BE 0770.537.019
Registered office: Donkstraat(MD) 11, 9170 Sint-Gillis-Waas
Names & denominations: DR. M.R. TROMP
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 30 June 2021
Peppol: Active · Active since 27 Mar 2026
Activities · NACE: Activiteiten van medisch specialisten

View on CBE Public ↗ Annual accounts (NBB) ↗